First pregabalin and now duloxetine for fibromyalgia syndrome: closer to a brave new world?

Affiliations

Comment

Chad S Boomershine. Nat Clin Pract Rheumatol. 2008 Dec.

. 2008 Dec;4(12):636-7.

doi: 10.1038/ncprheum0938. Epub 2008 Nov 4.

¹ Division of Rheumatology and Immunology, Vanderbilt University, Nashville, TN 37232-2681, USA. chad.boomershine@vanderbilt.edu

No abstract available

Comment on

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
Russell JI, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM. Russell JI, et al. Pain. 2008 Jun;136(3):432-444. doi: 10.1016/j.pain.2008.02.024. Epub 2008 Apr 18. Pain. 2008. PMID: 18395345 Clinical Trial.
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G. Arnold LM, et al. J Pain. 2008 Sep;9(9):792-805. doi: 10.1016/j.jpain.2008.03.013. Epub 2008 Jun 3. J Pain. 2008. PMID: 18524684 Clinical Trial.